Quick Answer
Vicarious Surgical Inc. reported Cash and Equivalents of $2.57 million for fiscal year 2025.
Vicarious Surgical Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.57M | -73.6% |
| 2024 | $9.74M | -81.6% |
| 2023 | $52.82M | -54.5% |
| 2022 | $116.21M | -33.0% |
| 2021 | $173.51M | +928.7% |
| 2020 | $16.87M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.16M | -55.2% | -19.1% |
| June 30, 2025 | $3.91M | -80.7% | +50.4% |
| March 31, 2025 | $2.60M | -93.2% | -73.3% |
| December 31, 2024 | $9.74M | -81.6% | +37.7% |
| September 30, 2024 | $7.07M | -88.0% | -65.1% |
| June 30, 2024 | $20.25M | -38.3% | -47.0% |
| March 31, 2024 | $38.22M | -29.3% | -27.6% |
| December 31, 2023 | $52.82M | -54.5% | -10.6% |
- Vicarious Surgical Inc. showed a decrease of -73.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, Vicarious Surgical Inc.’s cash and equivalents has declined by 84.8% (from $16.87 million to $2.57 million).
- The most recent figure is from Vicarious Surgical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: